Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

2/8/2022, 11:22 PM

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.

Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.

Congress
116

Number
S - 3353

Introduced on
2020-02-27

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

2/27/2020

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.

Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.

Alternative Names
Official Title as IntroducedA bill to amend title XVIII of the Social Security Act to provide for extended months of Medicare coverage of immunosuppressive drugs for kidney transplant patients, and for other purposes.

Policy Areas
Health

Potential Impact
Congressional oversight
Digestive and metabolic diseases
Drug therapy
Government studies and investigations
Health care coverage and access
Health promotion and preventive care
Medicare
Organ and tissue donation and transplantation
Prescription drugs

Comments

Recent Activity

Latest Summary7/21/2020

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals w...


Latest Action2/27/2020
Read twice and referred to the Committee on Finance.